Liofilchem novice - ComASP® Oritavancin

Antimicrobial resistance management

ComASP® Oritavancin
 

 
Oritavancin is a lipoglycopeptide with broad-spectrum activity against Gram-positive pathogens, such as staphylococci, including methicillin resistant Staphylococcus aureus (MRSA), streptococci and enterococci.  

ComASP® (Compact Antimicrobial Susceptibility Panel) Oritavancin is a 2-test panel containing the dried up antibiotic in 15 two-fold dilutions (0.001-16 μg/ml).  

ComASP® Oritavancin is used to perform the broth microdilution (BMD) method for the antimicrobial susceptibility testing of Oritavancin as recommended by international standards (i.e. CLSI, EUCAST, ISO 20776-1:2006).  

Choose among one of the following nine preset panels or request customized 32-well panel formats with over 100 antibiotics available:  
·     Oritavancin
·     Colistin
·     Piperacillin-tazobactam
·     Colistin / Piperacillin-tazobactam
·     Ceftolozane-tazobactam / Ceftazidime-avibactam
·     Vancomycin / Teicoplanin
·     Ceftolozane-tazobactam
·     Vancomycin
·     Antifungal  

Learn more about ComASP®